Piedmont Investment Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,489
Closed -$540K 998
2019
Q1
$540K Buy
6,489
+342
+6% +$24.8K 0.02% 501
2018
Q4
$395K Buy
6,147
+198
+3% +$13.5K 0.02% 565
2018
Q3
$471K Buy
5,949
+128
+2% +$9.9K 0.02% 547
2018
Q2
$426K Buy
5,821
+500
+9% +$34K 0.02% 502
2018
Q1
$337K Buy
5,321
+211
+4% +$12.6K 0.01% 526
2017
Q4
$260K Sell
5,110
-304
-6% -$15.8K 0.01% 621
2017
Q3
$284K Buy
5,414
+50
+0.9% +$2.51K 0.01% 597
2017
Q2
$273K Buy
+5,364
New +$265K 0.01% 597

Other funds holding CNMD

Piedmont Investment Advisors's CNMD Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of CONMED (CNMD) in Q2 2019, closing a stake of 6,489 shares — an estimated $540K sold.

Piedmont Investment Advisors first reported a position in CNMD in Q2 2017 and held it in 8 quarters. The position peaked at $540K in Q1 2019. 230 funds tracked by Wall St. Rank hold CNMD as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining CONMED position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 6,489 CONMED shares in Q2 2019, an estimated $540K.
  • Piedmont Investment Advisors first reported a position in CONMED in Q2 2017 and held it in 8 quarters.
  • Piedmont Investment Advisors's CONMED position peaked at $540K in Q1 2019.
  • 230 funds tracked by Wall St. Rank held CONMED as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.